Key facts
- It has raised $25.7M; the latest was Later Stage VC ($14.2M) in May 2025.
- Notable investors include Tech Incubator Program for Startup, IBK Changgong, Korea Credit Guarantee Fund, InterVest, Lotte Ventures — 23 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 23 names
- ·Watchlist + deal alerts for Curaum
- ·The full record, as it builds
Funding rounds
No funding rounds for Curaum are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Curaum
Developer of a smart oral denture cleaner intended to manage oral hygiene and sleep-related chronic diseases. The company's platform collects and analyzes consumers' medical, healthcare and sleep data to enable hygiene status to be monitored, symptoms before disease to be predicted, and early diagnosis to be done, enabling patients to make healthy habits for the prevention of disease rather than the treatment of disease.
- Sector
- Healthcare
- HQ
- Daejeon, South Korea
- Founded
- 2017
- Employees
- 28
- Website
- curaum.com/
- Ownership
- Privately Held (backing)
Curaum doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Curaum shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Curaum in its N-PORT filings yet. We sweep new filings monthly.